Top Markets
Coin of the day
Lipum AB (publ) Lipum AB (publ)

Lipum AB (publ)

LIPUM
Rank in Stocks #27266
Lipum AB (publ) is a biopharmaceutical firm based in Sweden, focused on... Lipum AB (publ) is a biopharmaceutical firm based in Sweden, focused on pioneering the discovery and development of therapeutic solutions for long-term inflammatory conditions. The company's primary therapeutic asset, SOL-116, is a humanized antibody currently in the late preclinical stage, designed to treat pediatric rheumatism and adult rheumatoid arthritis. To facilitate the advancement of SOL-116 into clinical trials, Lipum has established a collaboration with Pelago Bioscience AB to meticulously monitor drug targets. Founded in 2010, the company's operations are headquartered in UmeΓ₯, Sweden.
Share Price
$1.60
Last synced: 2026-03-18
Market Cap
$34.00M
Change (1 day)
0.70%
Change (1 year)
2.50%
Country
SE
Trade Lipum AB (publ) (LIPUM)

Category

EPS for Lipum AB (publ) (LIPUM)
EPS as of 2026 TTM: 0
According to Lipum AB (publ) latest financial reports and stock price the company's current EPS (TTM) is 0. At the end of 2026 the company had a EPS of 0 equal to its 2026 EPS that were of 0.
EPS history for Lipum AB (publ) from 2026 to 2026
EPS at the end of each year
Year EPS Change
Not enough data for the provided dates.
EPS for similar companies or competitors
Company EPS EPS Difference Country
$17.32 -
US
$-7.98 -
US
$27.74 -
NL
$2.98 -
AU
- -
CH